Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the cardiovascular system
- 1 September 1993
- journal article
- Published by Elsevier in Regulatory Peptides
- Vol. 47 (2) , 213-220
- https://doi.org/10.1016/0167-0115(93)90426-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Pituitary adenylate cyclase-activating polypeptide: a novel, long-lasting, endothelium-independent vasorelaxantPublished by Elsevier ,2002
- Pituitary adenylate cyclase activating polypeptide provokes cultured rat chromaffin cells to secrete adrenalineBiochemical and Biophysical Research Communications, 1992
- Elevation of plasma endothelin concentrations during endotoxin shock in dogsEuropean Journal of Pharmacology, 1991
- The Stimulatory Effect of PACAP 38 on Amylase Release in Dispersed Rat Pancreatic Acini.The Tohoku Journal of Experimental Medicine, 1991
- Adrenal pheochromocytoma PC12H cell respond to pituitary adenylate cyclase activating polypeptideBiochemical and Biophysical Research Communications, 1990
- Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38)Biochemical and Biophysical Research Communications, 1990
- Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cellsBiochemical and Biophysical Research Communications, 1989
- Production of endothelin 1 by cultured bovine retinal endothelial cells and presence of endothelin receptors on associated pericytesDiabetes, 1989
- Human diabetic serum does not stimulate bovine retinal endothelial cell growth in cultureCurrent Eye Research, 1989
- Phorbol esters modulate cyclic AMP accumulation in porcine thyroid cellsLife Sciences, 1988